Windtree Therapeutics

+$0.029 (+5.37%) Today
+$0.031 (+5.45%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WINT and other ETFs, options, and stocks.

About WINT

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases.

CEO
Craig E. Fraser
Employees
33
Headquarters
Warrington, Pennsylvania
Founded
1992

WINT Key Statistics

Market cap
16.73M
Price-Earnings ratio
—
Dividend yield
—
Average volume
281.95K
High today
$0.59
Low today
$0.54
Open price
$0.56
Volume
359.97K
52 Week high
$3.40
52 Week low
$0.48

WINT Earnings

-$0.54
-$0.36
-$0.17
$0.01
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure